arrow
Back
S

Susana Banerjee

The Royal Marsden NHS Foundation Trust and Institute of Cancer Research

71H-index
665Paper Count
3.0WCitation Count
Published Papers 187
Publication Date
Mirvetuximab soravtansine plus carboplatin in folate receptor alpha-expressing recurrent platinum-sensitive ovarian cancer
err2026-04-23
err0
PREAI
errGottfried Konecny; Peter Lim; Alessandro Santin; Lucy Gilbert; Angeles Alvarez Secord; Paul Bessette; Ursula Matulonis; Jayita Sen; Jaehyung Hong; Grace Lytle; Emarjola Bako; Sheri Spunt; Diane Provencher; Ainhoa Madariaga; Susana Banerjee; Ramez Eskander; Jose Alejandro Perez-Fidalgo; Dario Roque; Ana Oaknin
errShare
errSave
Phase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer
err2026-04-08
err0
PREAI
errYvette Drew; Lucy Gilbert; Alejandro Martinez Bueno; Ana Oaknin; Victor Moreno; Lydia Gaba Garcia; Gordon C. Jayson; Rebecca S. Kristeleit; Nehal Lakhani; Susana Banerjee; Daniela Matei; Amit Oza; Rowan Miller; Dennis Yiannakis; Maria-Pilar Barretina-Ginesta; Jerónimo Martínez García; Guanfang Wang; Jayalakshmi Miriyala; Amy Franke; Elisa Galvez; Lini Pandite; Debra L. Richardson
errShare
errSave
Ovarian cancer
err2026-03-05
err0
PREAI
errClare L. Scott; Susana Banerjee; Florence Joly; Jung-Min Lee; Asima Mukhopadhyay; David S. Tan; Elise C. Kohn
errShare
errSave
The combination of avutometinib and defactinib in treating recurrent low-grade serous ovarian cancer: a plain language summary of the Phase II clinical trial ENGOT-OV60/GOG-3052/RAMP 201
err2025-12-12
err0
errOAAI
errSusana N. Banerjee; Els Van Nieuwenhuysen; Carol Aghajanian; Véronique D’Hondt; Bradley J. Monk; Andrew Clamp; Emily Prendergast; Ana Oaknin; Kari Ring; Nicoletta Colombo; Robert W. Holloway; Manuel Rodrigues; Hye Sook Chon; Charlie Gourley; Alessandro D. Santin; Premal H. Thaker; Christine Gennigens; Gregg Newman; Erin Salinas; Hagop Youssoufian; Kathleen N. Moore; Stephanie Lustgarten; David M. O’Malley; Toon Van Gorp; Rachel N. Grisham
errShare
errSave
ARID1A stabilizes non-homologous end joining factors at DNA breaks induced by the G4 ligand pyridostatin
err2025-09-11
err0
errOAAI
errSusana Simões-Sousa; Noa Amin; Karen A. Lane; Alison Harrod; Malin Pedersen; Mercedes Pardo; Christine Rasetti-Escargueil; Zuzanna Kozik; Katheryn A.G. Begg; Alison Ribeiro; Susana Banerjee; Manuel Stucki; Kevin J. Harrington; Jyoti S. Choudhary; Jessica A. Downs
errShare
errSave
Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancer
err2025-07-31
err0
errOAAI
errEleonora Ghisoni; Fabrizio Benedetti; Aspram Minasyan; Mathieu Desbuisson; Paula Cunnea; Alizée J. Grimm; Noémie Fahr; Charlotte Capt; Nicolas Rayroux; Flavia De Carlo; Doga C. Gulhan; Julien Dagher; David Barras; Matteo Morotti; Juan A. Marín-Jiménez; Bovannak Stewen Chap; Tania Santoro; Giulia Spagnol; Mapi Fleury; Katerina Fortis; Julien Dorier; Mary K. Townsend; Stephanie Tissot; Sylvie Rusakiewicz; Humberto J. Ferreira; Anne I. Kraemer; Michal Bassani-Stenberg; Elizabeth M. Swisher; Lana A. Kandalaft; Spyridon A. Mastroyannis; Kathleen T. Montone; Daniel J. Powell; Susana Banerjee; Kathryn L. Terry; Shelley S. Tworoger; Mikaël J. Pittet; Janos L. Tanyi; George Coukos; Melissa A. Merritt; Christina Fotopoulou; Jose R. Conejo-Garcia; Denarda Dangaj Laniti
errShare
errSave
Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial
err2025-06-27
err0
errOAAI
errSusana Banerjee; Matthew G. Krebs; Alastair Greystoke; Alvaro Ingles Garces; Vicky Sanchez Perez; Angelika Terbuch; Rajiv Shinde; Reece Caldwell; Rafael Grochot; Mahtab Rouhifard; Ruth Ruddle; Bora Gurel; Karen Swales; Nina Tunariu; Toby Prout; Mona Parmar; Stefan Symeonides; Jan Rekowski; Christina Yap; Adam Sharp; Alec Paschalis; Juanita Lopez; Anna Minchom; Johann Sebastian de Bono; Udai Banerji
errShare
errSave
Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial
err2025-06-17
err0
errOAAI
errJonathan A. Ledermann; Amit M. Oza; Domenica Lorusso; Carol Aghajanian; Ana Oaknin; Andrew Dean; Nicoletta Colombo; Johanne I. Weberpals; Andrew R. Clamp; Giovanni Scambia; Alexandra Leary; Robert W. Holloway; Margarita Amenedo Gancedo; Peter C. Fong; Jeffrey C. Goh; David M. O’Malley; Deborah K. Armstrong; Susana Banerjee; Jesús García-Donas; Elizabeth M. Swisher; Robert L. Coleman
errShare
errSave
Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprogramming of the tumour microenvironment (vol 15, 1500570, 2024)
err2025-04-22
err0
errOAAI
errJennings, Victoria A.; Rumbold-Hall, Reah; Migneco, Gemma; Barr, Tyler; Reilly, Katrina; Ingram, Nicola; Hilare, Isabelle St; Heaton, Samuel; Alzamel, Noura; Jackson, David; Ralph, Christy; Banerjee, Susan; McNeish, Iain; Bell, John C.; Melcher, Alan A.; Ilkow, Carolina; Cook, Graham P.; Errington-Mais, Fiona
errShare
errSave
GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer
err2025-04-19
err0
errOAAI
errRachel Grisham; Bradley J. Monk; Els Van Nieuwenhuysen; Kathleen Nadine Moore; Michel Fabbro; David M. O’Malley; Ana Oaknin; Premal Thaker; Amit M. Oza; Nicoletta Colombo; David Gershenson; Carol A. Aghajanian; Chel Hun Choi; Yeh Chen Lee; Mansoor Raza Mirza; Robert L. Coleman; Lauren Cobb; Philipp Harter; Stephanie Lustgarten; Hagop Youssoufian; Susana Banerjee
errShare
errSave
Breast cancer outcomes in women with ovarian cancer and a pathogenic germline BRCA mutation
errEJSO
IF2.9
err2025-03-01
err0
PREAI
errAin, Quratul; O'Connell, Rachel L.; Swarnkar, Parinita; Mcveigh, Terri; George, Angela; Tasoulis, Marios K.; Gui, Gerald P. H.; Wiggins, Jennifer; Khan, Aadil A.; Krupa, Katherine D. C.; Barry, Peter A.; Banerjee, Susana; Rusby, Jennifer E.
errShare
errSave
Oncology professionals' perceptions and recommendations to improve well-being and health at work in times of crisis: qualitative thematic analysis from the ESMO Resilience Task Force survey series
err2025-03-01
err0
errOAAI
errHardy, C.; Thorne, E.; O'Connor, M.; Elez, E.; Kamposioras, K.; Punie, K.; Oing, C.; Murali, K.; Haanen, J. B. A. G.; Lim, K. H. J.; Banerjee, S.
errShare
errSave
Summary of Research: Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02
err2025-03-01
err0
errOAAI
errOaknin, Ana; Lee, Jung-Yun; Makker, Vicky; Oh, Do-Youn; Banerjee, Susana; Gonzalez-Martin, Antonio; Jung, Kyung Hae; Lugowska, Iwona; Manso, Luis; Manzano, Aranzazu; Melichar, Bohuslav; Siena, Salvatore; Stroyakovskiy, Daniil; Fielding, Anitra; Puvvada, Soham; Smith, Ann; Meric-Bernstam, Funda
errShare
errSave
Physician knowledge, use, and perceptions of genetic biomarker testing for the management of patients with newly diagnosed advanced ovarian cancer: an international physician survey
err2025-01-15
err0
errOAAI
errBanerjee, Susana; Eskander, Ramez N.; Bailey, Tom; Ambler, Will; Volpe, Stephanie; Ozgoren, Ozan; Grabowski, Jacek P.; Valabrega, Giorgio
errShare
errSave
Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprograming of the tumour microenvironment
err2024-12-23
err0
errOAAI
errJennings, Victoria A.; Rumbold-Hall, Reah; Migneco, Gemma; Barr, Tyler; Reilly, Katrina; Ingram, Nicola; St Hilare, Isabelle; Heaton, Samuel; Alzamel, Noura; Jackson, David; Ralph, Christy; Banerjee, Susan; Mcneish, Iain; Bell, John C.; Melcher, Alan A.; Ilkow, Carolina; Cook, Graham P.; Errington-Mais, Fiona
errShare
errSave
Two decades of advances in clinical oncology - lessons learned and future directions
err2024-10-01
err1
PREAI
errBanerjee, Susana; Booth, Christopher M.; Bruera, Eduardo; Buechler, Markus W.; Drilon, Alexander; Fry, Terry J.; Ghobrial, Irene M.; Gianni, Luca; Jain, Rakesh K.; Kroemer, Guido; Llovet, Josep M.; Long, Georgina V.; Pantel, Klaus; Pritchard-Jones, Kathy; Scher, Howard I.; Tabernero, Josep; Weichselbaum, Ralph R.; Weller, Michael; Wu, Yi-Long
errShare
errSave
ESMO Resilience Task Force recommendations to manage psychosocial risks, optimise well-being, and reduce burnout in oncology
err2024-10-01
err1
errOAAI
errLim, K. H. J.; Kamposioras, K.; Elez, E.; Haanen, J. B. A. G.; Hardy, C.; Murali, K.; O'Connor, M.; Oing, C.; Punie, K.; de Azambuja, E.; Blay, J. Y.; Banerjee, S.
errShare
errSave
Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02
err2024-09-11
err1
errOAAI
errOaknin, Ana; Lee, Jung-Yun; Makker, Vicky; Oh, Do-Youn; Banerjee, Susana; Gonzalez-Martin, Antonio; Jung, Kyung Hae; Lugowska, Iwona; Manso, Luis; Manzano, Aranzazu; Melichar, Bohuslav; Siena, Salvatore; Stroyakovskiy, Daniil; Fielding, Anitra; Puvvada, Soham; Smith, Ann; Meric-Bernstam, Funda
errShare
errSave
Oncologists' voices in time of crisis: Findings from the ESMO Resilience Task Force survey series on how members can be helped and supported e A qualitative analysis
err2024-09-01
err0
PREAI
errHardy, C.; Thorne, E.; O'Connor, M.; Fernandez, M. E. Elez; Kamposioras, K. V.; Punie, K.; Oing, C.; Murali, K.; Haanen, J. B. A. G.; Lim, K. H. J.; Banerjee, S.
errShare
errSave
ICON9: International phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy
err2024-09-01
err0
PREAI
errNicum, S.; Ledermann, J. A.; Mileshkin, L.; Jayson, G. C.; Gourley, C.; Michael, A.; Lord, R.; Mackay, H.; Hall, M.; Tookman, L.; Banerjee, S.; Harnett, P.; Macdonald, I.; Lee, Y. C.; Elyashiv, O.; Wilkinson, K.; Farrelly, L.; Counsell, N.
errShare
errSave